ReviewFrontiers in oncology2023

Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization.

Yi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.